Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05708222 · ClinicalTrials.gov registry record
Sleep Signal Analysis for Current Major Depressive Episode (SAMDE)
A clinical trial of Depression and Depressive Disorder, Major, sponsored by Medibio Limited.
- Completed
- Registry status
- 715
- Enrollment target
- 13
- Study locations
NCT05708222: Completed study of Depression and Depressive Disorder, Major, sponsored by Medibio Limited.
NCT05708222 is a study of Depression and Depressive Disorder, Major that has completed, run by Medibio Limited. The registered enrollment target is 715 participants, roughly in line with the 785-participant average among 679 other Depression trials with a reported enrollment target. The trial reports 13 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05708222, a study of Depression and Depressive Disorder, Major, has completed, sponsored by Medibio Limited.
- COMPLETED
- Registry status
- 715 participants
- Enrollment target
- 13
- Study locations
Study Summary
The objective of this study is to collect data to finalize the development of MEB-001 software as a medical device. The data collected in this study will be used to develop MEB-001 machine learning algorithms by training the algorithms to match the patient's demographic and clinical information, and the objective physiological signals (i.e., electroencephalogram (EEG) and electrocardiogram (ECG)) recorded during PSG with the diagnosis of cMDE performed through the MINI neuropsychiatric evaluation.
Primary Outcome
Evaluation of patient objective and subjective measures to develop algorithm to determine whether the patient is experiencing a current major depressive episode.
Conditions Studied
Interventions
- DEVICE MEB-001
Study Locations (13)
North Carolina
- Medbridge Healthcare - Clayton
- Medbridge Healthcare - Raleigh
- Medbridge Healthcare - Wilson
Texas
- Comprehensive Sleep Medicine Associates - Austin
- Comprehensive Sleep Medicine Associates - Sugar Land
- Comprehensive Sleep Medicine Associates - The Woodlands
Minnesota
- Lakeland Sleep Store - Blaine
- Lakeland Sleep - Plymouth
Ohio
- Ohio Sleep Solutions - Columbus
- Ohio Sleep Solutions - Grove City
South Carolina
- Medbridge Healthcare - North Charleston
- Medbridge Healthcare - Sumter
Florida
- Medbridge Healthcare - Bradenton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 715 participants |
| Start Date | 2022-09-01 |
| Est. Completion | 2024-07-09 |
What the finished NCT05708222 record still lists
NCT05708222 is an observational study that tracks outcomes without assigning an intervention. The registered 715 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 785-participant average among 679 other Depression trials with a reported enrollment target.
The record links to 5 conditions, with Depression appearing as the primary indexed condition, and to 1 intervention - of which MEB-001 is the first listed.
NCT05708222 lists 13 locations in 6 states (North Carolina, Texas, Minnesota).
Frequently Asked Questions
What is clinical trial NCT05708222 about?
NCT05708222 is a clinical study titled "Sleep Signal Analysis for Current Major Depressive Episode (SAMDE)". The objective of this study is to collect data to finalize the development of MEB-001 software as a medical device. The data collected in this study will be used to develop MEB-001 machine learning algorithms by training the algorithms to match the patient's demographic and clinical information, and...
What is the current status of trial NCT05708222?
This trial is currently completed. The enrollment target is 715 participants. The study started on 2022-09-01. Estimated completion is 2024-07-09.
What conditions does trial NCT05708222 study?
This clinical trial studies the following conditions: Depression, Depressive Disorder, Major, Depressive Disorder, Depression Mild, Depressive Episode.
What interventions are being tested in trial NCT05708222?
The interventions under investigation include: MEB-001 (DEVICE).
Who is sponsoring clinical trial NCT05708222?
This trial is sponsored by Medibio Limited, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05708222 being conducted?
This trial has 13 study locations across Florida, Minnesota, North Carolina, Ohio, South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05708222's enrollment target sits among peer trials
715 56th of 679 higher than 624 of 679 other Depression trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
Depression and Driving
RECRUITING
-
Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder
RECRUITING · Phase 1
-
Sleep to Reduce Incident Depression Effectively in Peripartum
RECRUITING · Phase 2
-
PET Imaging of Cyclooxygenase in Participants With Major Depressive Disorder (MDD)
RECRUITING · Phase 1
-
Identifying and Treating Depression in the Orthopaedic Trauma Population
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04680000 · 716 participants · NA
Chronic Pain Management In Primary Care Using Behavioral Health Consultants
- NCT05208762 · 714 participants · Phase 1
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
- NCT06758401 · 714 participants · Phase 3
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
- NCT04916327 · 720 participants · NA
Examining the Impact of Exercise Training on Vascular Dysfunction in Individuals With Mental Health Disorders - Study 1
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy